GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hwail Pharm Co Ltd (XKRX:061250) » Definitions » Total Long-Term Liabilities

Hwail Pharm Co (XKRX:061250) Total Long-Term Liabilities : ₩458 Mil (As of Mar. 2025)


View and export this data going back to 2002. Start your Free Trial

What is Hwail Pharm Co Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. Hwail Pharm Co's Total Long-Term Liabilities for the quarter that ended in Mar. 2025 was ₩458 Mil.

Hwail Pharm Co Total Long-Term Liabilities Historical Data

The historical data trend for Hwail Pharm Co's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hwail Pharm Co Total Long-Term Liabilities Chart

Hwail Pharm Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 453.57 417.67 2,082.88 521.95 481.33

Hwail Pharm Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Total Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 492.94 528.93 504.51 481.33 458.11

Hwail Pharm Co Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.

Hwail Pharm Co Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Hwail Pharm Co's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Hwail Pharm Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hwail Pharm Co Ltd (XKRX:061250) » Definitions » Total Long-Term Liabilities
Comparable Companies
XKRX:183490 XKRX:142280 XKRX:229500 XKRX:004310 XKRX:002800 XKRX:131030 XKRX:001540 XKRX:002720 XKRX:072020 XKRX:067290 ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
N/A
Address
904-7, Sangsin-Ri, Hyangnam-Eup, Hwaseong, Gyeonggi, KOR, 445-746
Website
http://www.hwail.com
Hwail Pharm Co Ltd is engaged in manufacturing and distribution of raw materials used in pharmaceutical production. Its products include antitussive expectorants, spasmolytic, stomach function modifier, anti-inflammatory, and others.

Hwail Pharm Co Headlines

No Headlines